Antibodies, monoclonal
Showing 7051 - 7075 of 7,894
Lymphoma Trial in United Kingdom (biological, dietary supplement, drug, other)
Withdrawn
- Lymphoma
- filgrastim
- +7 more
-
London, England, United Kingdom
- +4 more
Aug 23, 2013
Smallpox Trial in Lenexa, Lexington (ACAM3000 MVA Vaccine)
Completed
- Smallpox
- ACAM3000 MVA Vaccine
-
Lenexa, Kansas
- +1 more
Jan 9, 2014
Lymphoma, Small Intestine Cancer Trial in Stanford (visilizumab)
Completed
- Lymphoma
- Small Intestine Cancer
- visilizumab
-
Stanford, CaliforniaStanford University Medical Center
May 14, 2013
Colorectal Cancer Trial in United States (trastuzumab, irinotecan HCl)
Completed
- Colorectal Cancer
- trastuzumab
- irinotecan hydrochloride
-
Bronx, New York
- +4 more
Feb 7, 2013
Acute Gout Trial in Worldwide (Canakinumab 150 mg, Triamcinolone acetonide 40 mg, Placebo to canakinumab)
Completed
- Acute Gout
- Canakinumab 150 mg
- +3 more
-
Darlinghurst, New South Wales, Australia
- +46 more
Dec 24, 2013
Lymphoma Trial in Stanford (apolizumab)
Completed
- Lymphoma
- apolizumab
-
Stanford, CaliforniaStanford University Medical Center
May 14, 2013
Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell Trial in Worldwide (CP-751,871 (Figitumumab),
Terminated
- Carcinoma, Squamous Cell
- +3 more
- CP-751,871 (Figitumumab)
- +2 more
-
Florence, Alabama
- +279 more
Dec 11, 2013
Head Neck Cancer Trial in New York (biological, drug, radiation)
Completed
- Head and Neck Cancer
- cetuximab
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 17, 2013
Hepatitis C, Liver Transplantation Trial in Worldwide (Tacrolimus, steroids, monoclonal anti-IL2R antibody)
Completed
- Hepatitis C
- Liver Transplantation
- Tacrolimus
- steroids, monoclonal anti-IL2R antibody
-
Praha, Czech Republic
- +16 more
Apr 9, 2013
Leukemia, Lymphoma Trial in Philadelphia (rituximab, epirubicin HCl)
Completed
- Leukemia
- Lymphoma
- rituximab
- epirubicin hydrochloride
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 10, 2013
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (abagovomab)
Completed
- Fallopian Tube Cancer
- +2 more
- abagovomab
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 4, 2013
Breast Cancer Trial in Italy (biological, drug, procedure, radiation)
Unknown status
- Breast Cancer
- trastuzumab
- +11 more
-
Cuneo, Italy
- +5 more
Aug 6, 2013
Colorectal Cancer Trial in Los Angeles (Bevacizumab, Capecitabine, 5-Fluorouracil (5-FU))
Completed
- Colorectal Cancer
- Bevacizumab
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jun 19, 2013
B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +2 more
- tanespimycin
- rituximab
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
Breast Cancer Trial in United States (biological, drug, procedure, radiation)
Completed
- Breast Cancer
- bevacizumab
- +7 more
-
Cleveland, Ohio
- +4 more
Jun 14, 2013
Breast Cancer Trial in New York (trastuzumab, pegylated liposomal doxorubicin HCl)
Completed
- Breast Cancer
- trastuzumab
- pegylated liposomal doxorubicin hydrochloride
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 18, 2013
Diphtheria, Pertussis, Tetanus Trial in Muntinlupa City (Quinvaxem, Quinvaxem/Tritanrix)
Completed
- Diphtheria
- +4 more
- Quinvaxem
- Quinvaxem/Tritanrix
-
Muntinlupa City, PhilippinesResearch Institute for Tropical Medicine
Aug 29, 2013
Acute Gout Trial in Worldwide (Canakinumab 150 mg, Triamcinolone acetonide 40 mg, Placebo to canakinumab)
Completed
- Acute Gout
- Canakinumab 150 mg
- +3 more
-
Anniston, Alabama
- +107 more
Dec 24, 2013
Sarcoma Trial (trastuzumab)
Completed
- Sarcoma
- trastuzumab
- (no location specified)
Jun 21, 2013
Undifferentiated Arthritis Trial in Bruxelles (Infliximab, sodium chloride)
Completed
- Undifferentiated Arthritis
- Infliximab
- sodium chloride
-
Bruxelles, BelgiumUniversité Catholique de Louvain
Oct 30, 2013
Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, rituximab, sargramostim)
Terminated
- Lymphoma
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- +2 more
-
Birmingham, Alabama
- +59 more
Aug 1, 2013
Leukemia Trial in United Kingdom (rituximab, cyclophosphamide, fludarabine phosphate)
Completed
- Leukemia
- rituximab
- +3 more
-
Birmingham, England, United Kingdom
- +15 more
Aug 1, 2013
Lymphoma Trial (biological, drug, genetic, other)
Unknown status
- Lymphoma
- rituximab
- +10 more
- (no location specified)
Aug 1, 2013